The global pharmaceutical stability & storage services market size is calculated at US$ 3.4 billion in 2024, grew to US$ 3.59 billion in 2025, and is projected to reach around US$ 5.92 billion by 2034. The market is expanding at a CAGR of 5.7% between 2025 and 2034.
The Make in India initiative is transforming India’s global pharmaceutical footprint. For instance, in April 2025, the Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, reported that India has remained the largest vaccine supplier of UNICEF for the past 6-7 years, which contributes 55% to 60% of the total volume procured. It has also been reported that India contributes 99%, 52% and 45% of the WHO demand for DPT, BCG, and measles vaccines.
The Government of India is driving cost-to-innovation-based growth by robust research activities. For instance, in July 2025, the Ministry of Chemicals and Fertilizers announced that the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme was launched with an expenditure of ₹ 5,000 crore to transform the Pharma MedTech sector of India.
In December 2024, Kasim Kutay, CEO of Novo Holdings, announced that the company feels delighted to invite Alessandro and the talented Catalent team to the Novo Holdings family. Catalent Inc. plays a significant role in accelerating product development, product launch, and supply solutions for pharmaceutical, biotechnology, and consumer health companies. He also reported that the company’s mission aligns with the goal of Novo Holdings to invest for the well-being of people and planet.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com